Table 2.
ml/min/1.73 m2 | N at risk/N of events | IR (95% CI) | HR (95% CI) | |
---|---|---|---|---|
eGFR Creatinine | ≥ 60 | 15,749/4404 | 5.4 (5.2–5.6) | Ref. |
60–30 | 4381/2384 | 14.2 (13.6–14.7) | 2.4 (2.3–2.5) | |
30–20 | 1112/744 | 20.6 (19.2–22.2) | 3.4 (3.2–3.7) | |
< 20 | 1246/869 | 21.8 (20.4–23.3) | 3.6 (3.3–3.8) | |
eGFR Cystatin C | ≥ 60 | 13,271/3200 | 4.5 (4.3–4.7) | Ref. |
60–30 | 6103/2974 | 11.7 (11.2–12.1) | 2.4 (2.3–2.6) | |
30–20 | 1526/1027 | 21.2 (20.0–22.6) | 4.1 (3.8–4.4) | |
< 20 | 1588/1200 | 27.3 (25.8–28.9) | 5.0 (4.7–5.4) | |
eGFR Combined | ≥ 60 | 14,556/3734 | 4.8 (4.7–5.0) | Ref. |
60–30 | 5069/2649 | 13.2 (12.7–13.7) | 2.5 (2.4–2.6) | |
30–20 | 1347/902 | 20.6 (19.3–21.9) | 3.7 (3.5–4.0) | |
< 20 | 1516/1116 | 25.4 (23.9–26.9) | 4.4 (4.2–4.8) |
IR incidence rate, HR hazard ratio.